Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Successful treatment with gilteritinib for popliteal extramedullary relapse of FLT-3-ITD acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation : a case report and literature review

Дата публикации: 20-08-2026 11:35:05

An article created on 2026-08-20 11:35:05

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Clinical characteristics, treatment patterns, and overall survival in adolescent and young adult versus adult patients with non-M3 acute myeloid leukemia in Palestine: a retrospective single-center cohort study016.5319-08-2026
2Allogeneic HSCT Improves Prognosis in Advanced Extranodal NK/T-Cell Lymphoma023.3319-08-2026
3Prognostic factors and an exploratory risk stratification model in newly diagnosed Pola-R-CHP-treated diffuse large B-cell lymphoma: A real-world retrospective cohort analysis023.5420-08-2026
4Intermittent reduced-dose methotrexate enabled continuation of induction therapy despite severe delayed methotrexate elimination in primary central nervous system lymphoma: a case report0516-07-2026
5Contemporary Management of Acute Myeloid Leukemia010.4101-10-2024
6Circulating CD4+ T-Cell Differentiation Subsets Are Redistributed in HTLV-1–Associated Adult T-Cell Leukemia/Lymphoma029.9110-08-2026
7Durable Disease Control after Sequential Anlotinib Maintenance Therapy Following Local Radiotherapy in a Patient with Platinum-Refractory Recurrent Ovarian Clear Cell Carcinoma: A Case Report and Literature Review015.2810-08-2026
8A Case Report: An 11-year-old boy with peripheral T-cell lymphoma presenting after a five-year indolent inguinal lymphadenopathy020.2519-08-2026
9Talquetamab Plus Daratumumab and Pomalidomide and Talquetamab Plus Daratumumab Prolong PFS Among Previously Treated Patients with Relapsed Or Refractory Multiple Myeloma0502-07-2026
10Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma017.6920-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.23. Источник: www.researchsquare.com.